Pharma R&D Today

Considering lifestyle and environment to maximize the economic value of R&D

Posted on November 10th, 2017 by Dr Andrew A. Parsons in Pharma R&D

With an interest in systems approaches, I am always on the look-out for interesting papers in this area. A recent paper in Drug Discovery Today caught my eye for several reasons (1). The first was the extent of the problem with non-alcoholic liver disease. Continue reading “Considering lifestyle and environment to maximize the economic value of R&D” »